GlaxoSmithKline PLC ADR (GSK) Stock Analysis

GlaxoSmithKline PLC ADR (GSK) is a publicly traded company in the HEALTHCARE sector. It trades at $49.00, carries a market capitalization of $98.91B, a price-to-earnings ratio of 12.94, a dividend yield of 0.04%. This page summarizes the public market data, fundamentals, and frequently asked questions for GSK, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL

Exchange: NYSE

Key Metrics

Market Sentiment

GlaxoSmithKline PLC ADR currently has a Bullish sentiment score of 0.32.

About GlaxoSmithKline PLC ADR

GlaxoSmithKline PLC (GSK) is a prominent global biopharmaceutical company headquartered in Brentford, UK, dedicated to improving health outcomes through its innovative pharmaceuticals, vaccines, and consumer healthcare products. With a focus on robust research and development, GSK aims to tackle significant global health challenges while maintaining a diverse product portfolio across multiple therapeutic areas. The company’s strategic initiatives and commitment to advancing medical science po...

GNG Research Analysis

GNG Research scores GlaxoSmithKline PLC ADR (GSK) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for GSK.

Frequently Asked Questions

What is GSK's current dividend yield?

GlaxoSmithKline PLC ADR (GSK) has a current dividend yield of 0.04%.

Does GSK pay dividends?

Yes, GlaxoSmithKline PLC ADR pays dividends with a current yield of 0.04%.

What is GSK's P/E ratio?

GlaxoSmithKline PLC ADR has a price-to-earnings (P/E) ratio of 12.94.

What is GSK's market cap?

GlaxoSmithKline PLC ADR (GSK) has a market capitalization of $98.91B with a current stock price of $49.00.